thanks Dave....and the HER-Vaxx abstract posted online and available here:
Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+ metastatic or advanced gastric/GEJ adenocarcinoma - Final results from Phase II/HERIZON study (abstractsonline.com)
GLTAH
Media Thread, page-12957
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.004(7.29%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $2.716M | 53.26M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1474346 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 907490 | 19 |
View Market Depth
| Last trade - 13.39pm 18/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |